Gene Delivery

Delivery and Expression of DNA and RNA, A Laboratory Manual to Gene Transfer

Business Wire (Free subscription) | 29/10/2008

DUBLIN, Ireland--(BUSINESS WIRE)--Research and Markets (

Vical Receives Milestone Payment From Merck & Co., Inc. Triggered By Planned Initiation Of Investigational Cancer DNA Vaccine Trial

Medical News Today (Free subscription) | 02/12/2008

Vical Incorporated (Nasdaq: VICL) announced the receipt of a $1.0 million milestone payment from Merck & Co., Inc. based on Merck's planned initiation of a Phase I clinical trial of an investigational plasmid DNA (pDNA) cancer vaccine. The candidate vaccine is based on Vical's DNA gene delivery technology and encodes human telomerase reverse transcriptase (hTERT). hTERT is the subject...

• Vical Earns Merck Milestone - Contract Pharma Breaking News
• Vical Receives Milestone Payment from Merck & Co., Inc. Triggered by Planned Initiation of Investigational Cancer DNA Vaccine Trial - PR News Wire

Vical Earns Merck Milestone

Contract Pharma Breaking News (Free subscription) | 01/12/2008

Vical, Inc. received a $1.0 million milestone payment from Merck based on Merck's planned initiation of a Phase I trial of an investigational plasmid DNA (pDNA) cancer vaccine. The vaccine is based on Vical's DNA gene delivery technology and encodes human telomerase reverse transcriptase (hTERT), which is the subject of a separate license agreement. "The breadth of applications for Vical's...

Vical Executive Alain Rolland Named AAPS Fellow

PR News Wire (Free subscription) | 17/11/2008

As an executive with over 20 years of leadership experience at pharmaceutical and biotechnology companies, Dr. Rolland has contributed to creating novel delivery technologies and products that have been evaluated in human clinical trials. He started his career in advanced drug delivery, pioneering research on nanotechnologies that led to the development of novel nanoparticles administered...

Materials Medicine Mini-symposium: “Enabling Nanomaterials...

Virginia Biotechnology Association (Free subscription) | 17/11/2008

BLACKSBURG, Va., November 5, 2008 — To introduce the Southwest Virginia medical, materials, and business communities to the potential and current practice of materials medicine, the Macromolecules and Interfaces Institute (MII) and the Institute for Critical Technology and Applied Science (ICTAS) at Virginia Tech are sponsoring a program on “Enabling Nanomaterials for Advanced Drug Delivery,”...

DNA Vaccine Company Inovio Biomedical Reports Third Quarter 2008 Financial Results

Business Wire (Free subscription) | 07/11/2008

This press release contains certain forward-looking statements relating to our plans to develop our electroporation drug and gene delivery technology, our operations and strategic business events. Actual events or results may differ from our expectations as a result of a number of factors, including the uncertainties inherent in clinical trials and product development programs (including,...

Tiny DNA Tweezers Can Catch And Release Objects On-demand

Science Daily (Free subscription) | 03/11/2008

Researchers in China are reporting development of a new DNA "tweezers" that are the first of their kind capable of grasping and releasing objects on-demand. The microscopic tweezers could have several potential uses, the researchers note. Those include microsurgery, drug and gene delivery for gene therapy, and in the manufacturing of nano-sized circuits for futuristic electronics....

Tiny DNA Tweezers Can Catch And Release Objects On-demand - Journal Of The American Chemical Society

Medical News Today (Free subscription) | 29/10/2008

Researchers in China are reporting development of a new DNA "tweezers" that are the first of their kind capable of grasping and releasing objects on-demand. The microscopic tweezers could have several potential uses, the researchers note. Those include microsurgery, drug and gene delivery for gene therapy, and in the manufacturing of nano-sized circuits for futuristic electronics....